An Institute of Medicine (IOM) committee is urging the U.S. government to fund studies to compare treatment options for ADHD, Alzheimer's disease, and other conditions. The IOM committee is charged with offering recommendations about how the government can best use the 1.1 billion dollars set aside in the stimulus package to fund medical studies. In total, the IOM published a list of 100 recommendations for study, including areas such as cancer screening, physical education in schools, and...
Read moreImmunotherapy for Alzheimer's disease, commonly known as "the Alzheimer's Vaccine" has generated considerable excitement in both the... Read more »
We’ve been waiting for details and now they are here. The Obama administration plan to end Alzheimer’s disease by the year 2025 was... Read more »
Piling on the pounds as the years go by may pose more of a threat to your long-term health and well-being than you realize. In fact, being... Read more »
A new nicotine-like drug could improve memory and concentration in patients with attention-deficit/hyperactivity disorder without the health risks... Read more »
Drugmaker Tergacept's experimental ADHD medication is being moved into late-stage clinical trails, according to the company. The drug--known as... Read more »
Drugmaker Targacept Inc. says their experimental adult ADHD medication has met its primary target in a Phase II clinical trial. The... Read more »
For some, requesting accommodations help by giving extra assistance when needed. Not all adults with ADHD are comfortable asking for help. Adults,... Read more »
The Alzheimer’s Foundation of America (AFA) released the findings of their I CAN: Investigating Caregivers' Attitudes and Needs survey. The survey... Read more »